Position
Simplicity Wealth,LLC in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $175$772.20 → $772.41
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 845 | $652.5K | — | — | — | 0.0% |
| Q1 2026 | 947 | $731.5K | $772.41 | $175 | $78.8K | 0.0% |